Variant report

Variant	rs6564792
Chromosome Location	chr16:80840540-80840541
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	JUN	chr16:80840412-80841457	HUVEC	blood vessel:	n/a	chr16:80841335-80841343
2	MAX	chr16:80840522-80841292	Hela-S3	cervix:	n/a	n/a
3	POLR2A	chr16:80840430-80841278	HUVEC	blood vessel:	n/a	n/a
4	POLR2A	chr16:80840239-80841531	HUVEC	blood vessel:	n/a	n/a
5	POLR2A	chr16:80840418-80841224	Hela-S3	cervix:	n/a	n/a
6	POLR2A	chr16:80840421-80841451	Hela-S3	cervix:	n/a	n/a
7	FOS	chr16:80840240-80841511	HUVEC	blood vessel:	n/a	chr16:80841335-80841343
8	POLR2A	chr16:80840464-80841540	HUVEC	blood vessel:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr16:80625101..80626775-chr16:80839502..80841949,2	MCF-7	breast:
2	chr16:80840133..80841799-chr16:80886002..80888240,2	K562	blood:

Variant related genes	Relation type
CDYL2	TF binding region

Extended variants
information (count: 37 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:29)

rs_ID	r²[population]
rs11150315	0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs11150316	0.93[AMR][1000 genomes];0.93[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs11643914	0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs11645677	0.83[CHB][hapmap]
rs11646986	0.89[JPT][hapmap]
rs11865307	0.81[ASN][1000 genomes]
rs12443565	0.83[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs12444243	0.99[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12444274	0.96[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12446476	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.86[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];0.98[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12446987	0.83[AMR][1000 genomes];0.80[ASN][1000 genomes]
rs1544804	1.00[CEU][hapmap];1.00[CHB][hapmap];0.86[JPT][hapmap];0.95[YRI][hapmap];0.99[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1547990	1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.99[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs34450250	0.98[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs34502201	0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs34638446	0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs35690046	0.99[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs72820985	0.84[AMR][1000 genomes];0.84[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs74030456	0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs74030461	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs74030462	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs74030463	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs74030464	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs74030466	0.99[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs74030467	0.99[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8052178	0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8053834	0.99[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8053858	0.99[AFR][1000 genomes];0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8058727	0.99[AFR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1060621	chr16:80532848-80980616	Weak transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	29 gene(s)	inside rSNPs	diseases
2	nsv542989	chr16:80532848-80980616	Enhancers Active TSS ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	29 gene(s)	inside rSNPs	diseases
3	esv3451298	chr16:80696935-80997389	Weak transcription Enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases
4	esv3350075	chr16:80696955-80997359	Strong transcription Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases
5	nsv542990	chr16:80729797-80918198	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	12 gene(s)	inside rSNPs	diseases
6	nsv833301	chr16:80732170-80928751	Weak transcription Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	12 gene(s)	inside rSNPs	diseases
7	nsv457560	chr16:80825206-80858143	Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	9 gene(s)	inside rSNPs	diseases
8	nsv573302	chr16:80825206-80858143	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	9 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:33 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:80839200-80840600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
2	chr16:80839200-80840600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr16:80839200-80840800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
4	chr16:80839200-80841400	Weak transcription	Placenta	Placenta
5	chr16:80839200-80841600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
6	chr16:80839200-80843400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
7	chr16:80839400-80840600	Weak transcription	Primary T helper cells fromperipheralblood	blood
8	chr16:80840000-80841600	Enhancers	Primary hematopoietic stem cells	blood
9	chr16:80840000-80842000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr16:80840200-80840600	Enhancers	Muscle Satellite Cultured Cells	--
11	chr16:80840200-80840600	Enhancers	NHEK	skin
12	chr16:80840200-80841200	Enhancers	Primary T helper cells PMA-I stimulated	--
13	chr16:80840200-80841600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
14	chr16:80840400-80840600	Enhancers	Primary T killer memory cells from peripheral blood	blood
15	chr16:80840400-80840600	Enhancers	Brain Anterior Caudate	brain
16	chr16:80840400-80840600	Enhancers	NH-A	brain
17	chr16:80840400-80840600	Enhancers	Osteobl	bone
18	chr16:80840400-80840800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr16:80840400-80841000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
20	chr16:80840400-80841000	Flanking Active TSS	Hela-S3	cervix
21	chr16:80840400-80841000	Enhancers	HSMMtube	muscle
22	chr16:80840400-80841000	Flanking Active TSS	HUVEC	blood vessel
23	chr16:80840400-80841200	Enhancers	Primary T cells fromperipheralblood	blood
24	chr16:80840400-80841200	Enhancers	HSMM	muscle
25	chr16:80840400-80841200	Enhancers	NHDF-Ad	bronchial
26	chr16:80840400-80841400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
27	chr16:80840400-80841400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
28	chr16:80840400-80841400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr16:80840400-80841600	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr16:80840400-80841600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr16:80840400-80841800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr16:80840400-80842200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr16:80840400-80842600	Enhancers	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links